世界のエフリンB型受容体4市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Ephrin Type B Receptor 4 Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5725
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、85ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、エフリンB型受容体4の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（VDAU-11、Vas-01、トシレートテセバチニブ、その他）、用途別市場規模（固形腫瘍、胆管がん、結腸直腸がん、黒色腫、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・エフリンB型受容体4の市場動向
・企業の競争状況、市場シェア
・エフリンB型受容体4の種類別市場規模と予測2016-2027（VDAU-11、Vas-01、トシレートテセバチニブ、その他）
・エフリンB型受容体4の用途別市場規模と予測2016-2027（固形腫瘍、胆管がん、結腸直腸がん、黒色腫、その他）
・エフリンB型受容体4の北米市場規模2016-2027（アメリカ、カナダ）
・エフリンB型受容体4の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・エフリンB型受容体4のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・エフリンB型受容体4の中南米市場規模2016-2027（メキシコ、ブラジル）
・エフリンB型受容体4の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Eisai Co Ltd、Kadmon Corp LLC、VasGene Therapeutics Inc）
・結論

Market Analysis and Insights: Global Ephrin Type B Receptor 4 Market
The global Ephrin Type B Receptor 4 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ephrin Type B Receptor 4 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ephrin Type B Receptor 4 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ephrin Type B Receptor 4 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ephrin Type B Receptor 4 market.

Global Ephrin Type B Receptor 4 Scope and Market Size
Ephrin Type B Receptor 4 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ephrin Type B Receptor 4 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
VDAU-11
Vas-01
Tesevatinib Tosylate
Others

Segment by Application
Solid Tumor
Bile Duct Cancer
Colorectal Cancer
Melanoma
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Eisai Co Ltd
Kadmon Corp LLC
VasGene Therapeutics Inc

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ephrin Type B Receptor 4 Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 VDAU-11
1.2.3 Vas-01
1.2.4 Tesevatinib Tosylate
1.2.5 Others
1.3 Market by Application
1.3.1 Global Ephrin Type B Receptor 4 Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Solid Tumor
1.3.3 Bile Duct Cancer
1.3.4 Colorectal Cancer
1.3.5 Melanoma
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Ephrin Type B Receptor 4 Market Perspective (2016-2027)
2.2 Ephrin Type B Receptor 4 Growth Trends by Regions
2.2.1 Ephrin Type B Receptor 4 Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ephrin Type B Receptor 4 Historic Market Share by Regions (2016-2021)
2.2.3 Ephrin Type B Receptor 4 Forecasted Market Size by Regions (2022-2027)
2.3 Ephrin Type B Receptor 4 Industry Dynamic
2.3.1 Ephrin Type B Receptor 4 Market Trends
2.3.2 Ephrin Type B Receptor 4 Market Drivers
2.3.3 Ephrin Type B Receptor 4 Market Challenges
2.3.4 Ephrin Type B Receptor 4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Ephrin Type B Receptor 4 Players by Revenue
3.1.1 Global Top Ephrin Type B Receptor 4 Players by Revenue (2016-2021)
3.1.2 Global Ephrin Type B Receptor 4 Revenue Market Share by Players (2016-2021)
3.2 Global Ephrin Type B Receptor 4 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ephrin Type B Receptor 4 Revenue
3.4 Global Ephrin Type B Receptor 4 Market Concentration Ratio
3.4.1 Global Ephrin Type B Receptor 4 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ephrin Type B Receptor 4 Revenue in 2020
3.5 Ephrin Type B Receptor 4 Key Players Head office and Area Served
3.6 Key Players Ephrin Type B Receptor 4 Product Solution and Service
3.7 Date of Enter into Ephrin Type B Receptor 4 Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Ephrin Type B Receptor 4 Breakdown Data by Type
4.1 Global Ephrin Type B Receptor 4 Historic Market Size by Type (2016-2021)
4.2 Global Ephrin Type B Receptor 4 Forecasted Market Size by Type (2022-2027)

5 Ephrin Type B Receptor 4 Breakdown Data by Application
5.1 Global Ephrin Type B Receptor 4 Historic Market Size by Application (2016-2021)
5.2 Global Ephrin Type B Receptor 4 Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Ephrin Type B Receptor 4 Market Size (2016-2027)
6.2 North America Ephrin Type B Receptor 4 Market Size by Type
6.2.1 North America Ephrin Type B Receptor 4 Market Size by Type (2016-2021)
6.2.2 North America Ephrin Type B Receptor 4 Market Size by Type (2022-2027)
6.2.3 North America Ephrin Type B Receptor 4 Market Size by Type (2016-2027)
6.3 North America Ephrin Type B Receptor 4 Market Size by Application
6.3.1 North America Ephrin Type B Receptor 4 Market Size by Application (2016-2021)
6.3.2 North America Ephrin Type B Receptor 4 Market Size by Application (2022-2027)
6.3.3 North America Ephrin Type B Receptor 4 Market Size by Application (2016-2027)
6.4 North America Ephrin Type B Receptor 4 Market Size by Country
6.4.1 North America Ephrin Type B Receptor 4 Market Size by Country (2016-2021)
6.4.2 North America Ephrin Type B Receptor 4 Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Ephrin Type B Receptor 4 Market Size (2016-2027)
7.2 Europe Ephrin Type B Receptor 4 Market Size by Type
7.2.1 Europe Ephrin Type B Receptor 4 Market Size by Type (2016-2021)
7.2.2 Europe Ephrin Type B Receptor 4 Market Size by Type (2022-2027)
7.2.3 Europe Ephrin Type B Receptor 4 Market Size by Type (2016-2027)
7.3 Europe Ephrin Type B Receptor 4 Market Size by Application
7.3.1 Europe Ephrin Type B Receptor 4 Market Size by Application (2016-2021)
7.3.2 Europe Ephrin Type B Receptor 4 Market Size by Application (2022-2027)
7.3.3 Europe Ephrin Type B Receptor 4 Market Size by Application (2016-2027)
7.4 Europe Ephrin Type B Receptor 4 Market Size by Country
7.4.1 Europe Ephrin Type B Receptor 4 Market Size by Country (2016-2021)
7.4.2 Europe Ephrin Type B Receptor 4 Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Ephrin Type B Receptor 4 Market Size (2016-2027)
8.2 Asia-Pacific Ephrin Type B Receptor 4 Market Size by Type
8.2.1 Asia-Pacific Ephrin Type B Receptor 4 Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ephrin Type B Receptor 4 Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ephrin Type B Receptor 4 Market Size by Type (2016-2027)
8.3 Asia-Pacific Ephrin Type B Receptor 4 Market Size by Application
8.3.1 Asia-Pacific Ephrin Type B Receptor 4 Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ephrin Type B Receptor 4 Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ephrin Type B Receptor 4 Market Size by Application (2016-2027)
8.4 Asia-Pacific Ephrin Type B Receptor 4 Market Size by Region
8.4.1 Asia-Pacific Ephrin Type B Receptor 4 Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ephrin Type B Receptor 4 Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Ephrin Type B Receptor 4 Market Size (2016-2027)
9.2 Latin America Ephrin Type B Receptor 4 Market Size by Type
9.2.1 Latin America Ephrin Type B Receptor 4 Market Size by Type (2016-2021)
9.2.2 Latin America Ephrin Type B Receptor 4 Market Size by Type (2022-2027)
9.2.3 Latin America Ephrin Type B Receptor 4 Market Size by Type (2016-2027)
9.3 Latin America Ephrin Type B Receptor 4 Market Size by Application
9.3.1 Latin America Ephrin Type B Receptor 4 Market Size by Application (2016-2021)
9.3.2 Latin America Ephrin Type B Receptor 4 Market Size by Application (2022-2027)
9.3.3 Latin America Ephrin Type B Receptor 4 Market Size by Application (2016-2027)
9.4 Latin America Ephrin Type B Receptor 4 Market Size by Country
9.4.1 Latin America Ephrin Type B Receptor 4 Market Size by Country (2016-2021)
9.4.2 Latin America Ephrin Type B Receptor 4 Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Ephrin Type B Receptor 4 Market Size (2016-2027)
10.2 Middle East & Africa Ephrin Type B Receptor 4 Market Size by Type
10.2.1 Middle East & Africa Ephrin Type B Receptor 4 Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ephrin Type B Receptor 4 Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ephrin Type B Receptor 4 Market Size by Type (2016-2027)
10.3 Middle East & Africa Ephrin Type B Receptor 4 Market Size by Application
10.3.1 Middle East & Africa Ephrin Type B Receptor 4 Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ephrin Type B Receptor 4 Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ephrin Type B Receptor 4 Market Size by Application (2016-2027)
10.4 Middle East & Africa Ephrin Type B Receptor 4 Market Size by Country
10.4.1 Middle East & Africa Ephrin Type B Receptor 4 Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ephrin Type B Receptor 4 Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Eisai Co Ltd
11.1.1 Eisai Co Ltd Company Details
11.1.2 Eisai Co Ltd Business Overview
11.1.3 Eisai Co Ltd Ephrin Type B Receptor 4 Introduction
11.1.4 Eisai Co Ltd Revenue in Ephrin Type B Receptor 4 Business (2016-2021)
11.1.5 Eisai Co Ltd Recent Development
11.2 Kadmon Corp LLC
11.2.1 Kadmon Corp LLC Company Details
11.2.2 Kadmon Corp LLC Business Overview
11.2.3 Kadmon Corp LLC Ephrin Type B Receptor 4 Introduction
11.2.4 Kadmon Corp LLC Revenue in Ephrin Type B Receptor 4 Business (2016-2021)
11.2.5 Kadmon Corp LLC Recent Development
11.3 VasGene Therapeutics Inc
11.3.1 VasGene Therapeutics Inc Company Details
11.3.2 VasGene Therapeutics Inc Business Overview
11.3.3 VasGene Therapeutics Inc Ephrin Type B Receptor 4 Introduction
11.3.4 VasGene Therapeutics Inc Revenue in Ephrin Type B Receptor 4 Business (2016-2021)
11.3.5 VasGene Therapeutics Inc Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Ephrin Type B Receptor 4 Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of VDAU-11
Table 3. Key Players of Vas-01
Table 4. Key Players of Tesevatinib Tosylate
Table 5. Key Players of Others
Table 6. Global Ephrin Type B Receptor 4 Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Ephrin Type B Receptor 4 Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Ephrin Type B Receptor 4 Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Ephrin Type B Receptor 4 Market Share by Regions (2016-2021)
Table 10. Global Ephrin Type B Receptor 4 Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Ephrin Type B Receptor 4 Market Share by Regions (2022-2027)
Table 12. Ephrin Type B Receptor 4 Market Trends
Table 13. Ephrin Type B Receptor 4 Market Drivers
Table 14. Ephrin Type B Receptor 4 Market Challenges
Table 15. Ephrin Type B Receptor 4 Market Restraints
Table 16. Global Ephrin Type B Receptor 4 Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Ephrin Type B Receptor 4 Market Share by Players (2016-2021)
Table 18. Global Top Ephrin Type B Receptor 4 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ephrin Type B Receptor 4 as of 2020)
Table 19. Ranking of Global Top Ephrin Type B Receptor 4 Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Ephrin Type B Receptor 4 Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Ephrin Type B Receptor 4 Product Solution and Service
Table 23. Date of Enter into Ephrin Type B Receptor 4 Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Ephrin Type B Receptor 4 Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Ephrin Type B Receptor 4 Revenue Market Share by Type (2016-2021)
Table 27. Global Ephrin Type B Receptor 4 Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Ephrin Type B Receptor 4 Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Ephrin Type B Receptor 4 Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Ephrin Type B Receptor 4 Revenue Market Share by Application (2016-2021)
Table 31. Global Ephrin Type B Receptor 4 Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Ephrin Type B Receptor 4 Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Ephrin Type B Receptor 4 Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Ephrin Type B Receptor 4 Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Ephrin Type B Receptor 4 Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Ephrin Type B Receptor 4 Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Ephrin Type B Receptor 4 Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Ephrin Type B Receptor 4 Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Ephrin Type B Receptor 4 Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Ephrin Type B Receptor 4 Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Ephrin Type B Receptor 4 Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Ephrin Type B Receptor 4 Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Ephrin Type B Receptor 4 Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Ephrin Type B Receptor 4 Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Ephrin Type B Receptor 4 Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Ephrin Type B Receptor 4 Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Ephrin Type B Receptor 4 Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Ephrin Type B Receptor 4 Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Ephrin Type B Receptor 4 Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Ephrin Type B Receptor 4 Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Ephrin Type B Receptor 4 Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Ephrin Type B Receptor 4 Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Ephrin Type B Receptor 4 Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Ephrin Type B Receptor 4 Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Ephrin Type B Receptor 4 Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Ephrin Type B Receptor 4 Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Ephrin Type B Receptor 4 Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Ephrin Type B Receptor 4 Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Ephrin Type B Receptor 4 Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Ephrin Type B Receptor 4 Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Ephrin Type B Receptor 4 Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Ephrin Type B Receptor 4 Market Size by Country (2022-2027) & (US$ Million)
Table 63. Eisai Co Ltd Company Details
Table 64. Eisai Co Ltd Business Overview
Table 65. Eisai Co Ltd Ephrin Type B Receptor 4 Product
Table 66. Eisai Co Ltd Revenue in Ephrin Type B Receptor 4 Business (2016-2021) & (US$ Million)
Table 67. Eisai Co Ltd Recent Development
Table 68. Kadmon Corp LLC Company Details
Table 69. Kadmon Corp LLC Business Overview
Table 70. Kadmon Corp LLC Ephrin Type B Receptor 4 Product
Table 71. Kadmon Corp LLC Revenue in Ephrin Type B Receptor 4 Business (2016-2021) & (US$ Million)
Table 72. Kadmon Corp LLC Recent Development
Table 73. VasGene Therapeutics Inc Company Details
Table 74. VasGene Therapeutics Inc Business Overview
Table 75. VasGene Therapeutics Inc Ephrin Type B Receptor 4 Product
Table 76. VasGene Therapeutics Inc Revenue in Ephrin Type B Receptor 4 Business (2016-2021) & (US$ Million)
Table 77. VasGene Therapeutics Inc Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ephrin Type B Receptor 4 Market Share by Type: 2020 VS 2027
Figure 2. VDAU-11 Features
Figure 3. Vas-01 Features
Figure 4. Tesevatinib Tosylate Features
Figure 5. Others Features
Figure 6. Global Ephrin Type B Receptor 4 Market Share by Application: 2020 VS 2027
Figure 7. Solid Tumor Case Studies
Figure 8. Bile Duct Cancer Case Studies
Figure 9. Colorectal Cancer Case Studies
Figure 10. Melanoma Case Studies
Figure 11. Others Case Studies
Figure 12. Ephrin Type B Receptor 4 Report Years Considered
Figure 13. Global Ephrin Type B Receptor 4 Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Ephrin Type B Receptor 4 Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Ephrin Type B Receptor 4 Market Share by Regions: 2020 VS 2027
Figure 16. Global Ephrin Type B Receptor 4 Market Share by Regions (2022-2027)
Figure 17. Global Ephrin Type B Receptor 4 Market Share by Players in 2020
Figure 18. Global Top Ephrin Type B Receptor 4 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ephrin Type B Receptor 4 as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Ephrin Type B Receptor 4 Revenue in 2020
Figure 20. Global Ephrin Type B Receptor 4 Revenue Market Share by Type (2016-2021)
Figure 21. Global Ephrin Type B Receptor 4 Revenue Market Share by Type (2022-2027)
Figure 22. North America Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Ephrin Type B Receptor 4 Market Share by Type (2016-2027)
Figure 24. North America Ephrin Type B Receptor 4 Market Share by Application (2016-2027)
Figure 25. North America Ephrin Type B Receptor 4 Market Share by Country (2016-2027)
Figure 26. United States Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Ephrin Type B Receptor 4 Market Share by Type (2016-2027)
Figure 30. Europe Ephrin Type B Receptor 4 Market Share by Application (2016-2027)
Figure 31. Europe Ephrin Type B Receptor 4 Market Share by Country (2016-2027)
Figure 32. Germany Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Ephrin Type B Receptor 4 Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Ephrin Type B Receptor 4 Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Ephrin Type B Receptor 4 Market Share by Region (2016-2027)
Figure 42. China Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Ephrin Type B Receptor 4 Market Share by Type (2016-2027)
Figure 50. Latin America Ephrin Type B Receptor 4 Market Share by Application (2016-2027)
Figure 51. Latin America Ephrin Type B Receptor 4 Market Share by Country (2016-2027)
Figure 52. Mexico Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Ephrin Type B Receptor 4 Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Ephrin Type B Receptor 4 Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Ephrin Type B Receptor 4 Market Share by Country (2016-2027)
Figure 58. Turkey Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Ephrin Type B Receptor 4 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Eisai Co Ltd Revenue Growth Rate in Ephrin Type B Receptor 4 Business (2016-2021)
Figure 62. Kadmon Corp LLC Revenue Growth Rate in Ephrin Type B Receptor 4 Business (2016-2021)
Figure 63. VasGene Therapeutics Inc Revenue Growth Rate in Ephrin Type B Receptor 4 Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界のインターロイキン12受容体市場規模・現状・予測（2021年-2027年）

Global Interleukin 12 Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5806 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、インターロイキン12受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エドデキンアルファSR、M-9241、LY-3232094、NMIL-121、その他）、用途別市場規模（入院患者、外来患者）、...

世界のC-X-Cケモカイン受容体タイプ1市場規模・現状・予測（2021年-2027年）

Global C-X-C Chemokine Receptor Type 1 Market Size, Status and Forecast 2021-2027
QFJ1-5683 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、C-X-Cケモカイン受容体タイプ1の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（DF-2755A、PAC-G31P、レパリキシン、SX-576、その他）、用途別市場規模（炎症、肺がん、黒色腫、術後痛...

世界のN-ホルミルペプチド受容体2市場規模・現状・予測（2021年-2027年）

Global N-Formyl Peptide Receptor 2 Market Size, Status and Forecast 2021-2027
QFJ1-5886 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、N-ホルミルペプチド受容体2の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（TR-8、NCP-70X、ヒューマニン、その他）、用途別市場規模（炎症、2型糖尿病、アレルギー、脳虚血、転移性がん、その他）...

世界のブラジキニンB1受容体市場規模・現状・予測（2021年-2027年）

Global Bradykinin B1 Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5635 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、ブラジキニンB1受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（BI-113823、その他）、用途別市場規模（診療所、病院、家庭用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界のα2Cアドレナリン受容体市場規模・現状・予測（2021年-2027年）

Global Alpha 2C Adrenergic Receptor Market Size, Status and Forecast 2021-2027
QFJ1-5572 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、α2Cアドレナリン受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ラクリペップ、JNJ-4789、SKL-PSY、その他）、用途別市場規模（双極性障害、ドライアイ、大うつ病、その他）、主要地域別...

世界のGLP-1受容体アゴニスト市場規模・現状・予測（2021年-2027年）

Global GLP-1 Receptor Agonists Market Size, Status and Forecast 2021-2027
QFJ1-4259 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、GLP-1受容体アゴニストの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エクセナチド、リラグルチド、リキシセナチド、アルビグルチド、その他）、用途別市場規模（固形腫瘍、血液関連腫瘍）、主要地域別市場...

世界のトロンボポエチン受容体市場規模・現状・予測（2021年-2027年）

Global Thrombopoietin Receptor Market Size, Status and Forecast 2021-2027
QFJ1-6039 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、トロンボポエチン受容体の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エルトロンボパグオラミン、GSK-2285921、ロミプロスティム、STST-4、その他）、用途別市場規模（クリニック、病院、その...

世界のプロスタグランジンE2受容体EP2サブタイプ市場規模・現状・予測（2021年-2027年）

Global Prostaglandin E2 Receptor EP2 Subtype Market Size, Status and Forecast 2021-2027
QFJ1-5966 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、プロスタグランジンE2受容体EP2サブタイプの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（TG-4155、SAR-366234、ONO-8055、トレプロスチニル、その他）、用途別市場規模（クリニッ...

世界のメラノコルチン受容体4市場規模・現状・予測（2021年-2027年）

Global Melanocortin Receptor 4 Market Size, Status and Forecast 2021-2027
QFJ1-5849 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、メラノコルチン受容体4の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ブレメラノチド、コルチコトロピン、コシントロピン、その他）、用途別市場規模（代謝障害、女性健康、泌尿生殖器系、感染症、その他）、主...

世界のC-X-Cケモカイン受容体タイプ2市場規模・現状・予測（2021年-2027年）

Global C-X-C Chemokine Receptor Type 2 Market Size, Status and Forecast 2021-2027
QFJ1-5684 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、C-X-Cケモカイン受容体タイプ2の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（DF-2755A、AZD-5069、PAC-G31P、SX-517、その他）、用途別市場規模（冠状動脈疾患、肝移植拒絶...

世界の胆管がん用治療薬市場規模・現状・予測（2021年-2027年） Bile Duct Cancer is a rare type of cancer that mainly affects adults aged over 65. Bile ducts are small tubes that connect the liver and small intestine that allow fluid called bile to flow from the liver, through the pancreas, to the gut, where it helps with digestion. Market Analysis and Insights:…
世界の胆管がん治療薬市場規模・現状・予測（2021年-2027年） Bile duct connects the liver to the gallbladder and carries bile, which is synthesized by the liver and stored in the gallbladder. The main function of bile is breakdown of fat during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The specific cause of bile duct cancer is unkno…
世界の固形腫瘍がん治療市場規模・現状・予測（2021年-2027年） An abnormal mass of tissue that usually does not contain cysts or liquid areas. Market Analysis and Insights: Global Solid Tumor Cancer Treatment Market The global Solid Tumor Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% dur…
世界の腫瘍壊死因子受容体スーパーファミリーメンバー9市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tumor Necrosis Factor Receptor Superfamily Member 9 Market The global Tumor Necrosis Factor Receptor Superfamily Member 9 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-stand…
世界の膵臓＆胆管がん治療薬市場規模・現状・予測（2021年-2027年） It is a drug for treating pancreatic cancer with bile duct cancer. Pancreatic cancer is a disease in which malignant (cancer) cells are found in pancreatic tissue. The pancreas is a large gland located in the abdominal cavity and is responsible for the secretion of digestive juice and insulin. Sympt…